Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 343

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 343
---
 shall have paid off, redeemed or satisfied all of its Vendor Indebtedness; •NLS shall have terminated the employment and engagement of all of its employees and consultants and paid or otherwise satisfied all back pay, severance or termination pay, vacation pay and all other liabilities in respect of all such employment and engagement; •Nasdaq shall have rescinded its notice to NLS as to NLS’s failure to satisfy Nasdaq criteria for listing and trade thereon. On October29, 2024, the Company updated that NLS announced on October28, 2024, that it had received final approval from Nasdaq confirming that it meets the requirements to continue trading; •NLS shall have at least $600,000 in gross funds (including cash in any of its bank accounts); •The (i) directors of NLS immediately prior to the Effective Time shall have resigned from their positions (other than Mr. Zwyer), (ii) officers of NLS immediately prior to the Effective Time shall have resigned from their positions (other than Mr. Konofal who shall remain in a part -timeposition with NLS), (iii) the executive officers of Kadimastem immediately prior to the Effective Time shall be appointed as executive officers of NLS, and (iv) NLS shall have convened the shareholder meeting and shall have elected Kadimastem’s Board members as members of the NLS Board, effective as of the Effective Time; and •NLS Common Shares shall remain listed on the Nasdaq and shall not be subject to a delisting notice from Nasdaq. The notification form for the listing of NLS Common Shares to be issued in connection with the Merger shall have been accepted and approved (subject to official notice of issuance), and the Nasdaq listing application for initial listing of NLS following the Merger and of NLS Common Shares being issued pursuant to the Merger Agreement shall have been approved. 160 Completion and Effectiveness of the Merger The Closing is expected to take place (i) no later than the second business day following the satisfaction or waiver of the conditions described below under the section titled “ Conditions to the Consummation of the Merger” or (ii) on such other date as agreed to by the parties to the Merger Agreement in writing, in each case, subject to the satisfaction or waiver of the closing conditions. However, because the Merger is subject to a number of conditions, neither NLS nor Kadimastem can predict exactly when the closing of the